M S Rasin - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Terapevticheskii Arkhiv|November 23, 2013

[Peroxisome proliferator-activated receptors-gamma and hypertension: lessons of the history of researches]M S Rasin

Likars'Ka Sprava|April 25, 2015

[Peroxysome proliferator-activated receptors at pathogenesis and treatment of atherosclerosis (achievements, paradoxes and perspectives)]M S Rasin

Likars'Ka Sprava|October 8, 2014

[Modern methods of correction of systemic inflammation and insulin resistance by patients with coronary heart disease and diabetes mellitus type 2]M S Rasin, Z A Shaenko

Likars'Ka Sprava|February 28, 2006

[Clinical efficiency of candesatran depends on angiotension II receptor, type 1 gene polymorphism]I P Kaĭdashev, M S Rasin, L G Savchenko, et al.

Tsitologiia I Genetika|January 10, 2006

[Polymorphism of the angiotensin II type 1 receptor in patients with essential hypertension in Ukrainian population]I P Kaĭdashev, M S Rasin, L G Savchenko, et al.

Likars'Ka Sprava|September 30, 2011

[Efficacy of metformin as initial therapy in patients with coronary artery disease and diabetes type 2]A V Lavrenko, L A Kutsenko, I L Solokhina, et al.

Likars'Ka Sprava|February 23, 2007

[Clinical efficiency of candesartan in patients with renoparenchymal hypertension in dependence on genotype of angeotensin II receptors of I type]I P Kaĭdashev, M S Rasin, I A Nerukh, et al.

Likars'Ka Sprava|July 1, 2011

[Efficacy of short-term metformin application in complex treatment of patients with coronary artery disease and concomitant metabolic syndrome]A V Lavrenko, M S Rasin, L A Kutsenko, et al.

Tsitologiia I Genetika|February 14, 2008

[Frequency of the Pro 12Ala polymorphism of PPARgamma2 gene in Ukrainian population and its possible role in development of metabolic syndrome]I P Kaĭdashev, A M Rasin, O A Shlykova, et al.

Likars'Ka Sprava|April 13, 2007

[Metabolic syndrome in men of 35-65 years old from rural district of Poltava region and possibility of the prophylactic therapy with atorvastatine]I P Kaĭdashev, V N Vasil'ev, I M Gorbas', et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Terapevticheskii Arkhiv|November 23, 2013

[Peroxisome proliferator-activated receptors-gamma and hypertension: lessons of the history of researches]M S Rasin

Likars'Ka Sprava|April 25, 2015

[Peroxysome proliferator-activated receptors at pathogenesis and treatment of atherosclerosis (achievements, paradoxes and perspectives)]M S Rasin

Likars'Ka Sprava|October 8, 2014

[Modern methods of correction of systemic inflammation and insulin resistance by patients with coronary heart disease and diabetes mellitus type 2]M S Rasin, Z A Shaenko

Likars'Ka Sprava|February 28, 2006

[Clinical efficiency of candesatran depends on angiotension II receptor, type 1 gene polymorphism]I P Kaĭdashev, M S Rasin, L G Savchenko, et al.

Tsitologiia I Genetika|January 10, 2006

[Polymorphism of the angiotensin II type 1 receptor in patients with essential hypertension in Ukrainian population]I P Kaĭdashev, M S Rasin, L G Savchenko, et al.

Likars'Ka Sprava|September 30, 2011

[Efficacy of metformin as initial therapy in patients with coronary artery disease and diabetes type 2]A V Lavrenko, L A Kutsenko, I L Solokhina, et al.

Likars'Ka Sprava|February 23, 2007

[Clinical efficiency of candesartan in patients with renoparenchymal hypertension in dependence on genotype of angeotensin II receptors of I type]I P Kaĭdashev, M S Rasin, I A Nerukh, et al.

Likars'Ka Sprava|July 1, 2011

[Efficacy of short-term metformin application in complex treatment of patients with coronary artery disease and concomitant metabolic syndrome]A V Lavrenko, M S Rasin, L A Kutsenko, et al.

Tsitologiia I Genetika|February 14, 2008

[Frequency of the Pro 12Ala polymorphism of PPARgamma2 gene in Ukrainian population and its possible role in development of metabolic syndrome]I P Kaĭdashev, A M Rasin, O A Shlykova, et al.

Likars'Ka Sprava|April 13, 2007

[Metabolic syndrome in men of 35-65 years old from rural district of Poltava region and possibility of the prophylactic therapy with atorvastatine]I P Kaĭdashev, V N Vasil'ev, I M Gorbas', et al.

Pageof 1